Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

$12M Private Funding To Help CepTor Push Myodur Program

Feb. 1, 2005

By Aaron Lorenzo

La Jolla Pharmaceutical Raising $17M Through Public Stock Sale

Jan. 31, 2005

By Aaron Lorenzo

Leavitt To Head HHS After Receiving Senate Support

Jan. 31, 2005

By Aaron Lorenzo

La Jolla Pharmaceutical Raising $17M Through Public Stock Sale

Jan. 31, 2005

By Aaron Lorenzo

Leavitt To Head HHS After Receiving Senate Support

Jan. 31, 2005

By Aaron Lorenzo

Theravance Begins Second Phase III Trial For Telavancin

Jan. 28, 2005

By Aaron Lorenzo

Theravance Begins Second Phase III Trial For Telavancin

Jan. 28, 2005

By Aaron Lorenzo

ImClone Enters Patent License Deals With Genentech, Centocor

Jan. 27, 2005

By Aaron Lorenzo

GTx's Acapodene Moves To Second Oncology Phase III

Jan. 27, 2005

By Aaron Lorenzo

GTx's Acapodene Moves To Second Oncology Phase III

Jan. 27, 2005

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...